NASDAQ · Healthcare · Medical - Diagnostics & Research
Myriad Genetics, Inc.
MYGN
Myriad Genetics, Inc. CEO Samraat S. Raha · Market cap $367.1M.
$3.89
-0.18 · -4.49%
52w hi $8.5952w lo $3.75
Off 52w high 44.4%
62
NOTABLE
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $6.00
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 09 | Samraat S. Raha | President and CEO | Buy | 40,000 | $5.00 | +$200K | 62 |
| Feb 27 | Louise S. Phanstiel | Buy | 48,000 | $4.66 | +$224K | 56 | |
| Feb 26 | Louise S. Phanstiel | Buy | 50,407 | $4.80 | +$242K | 60 | |
| Feb 25 | Louise S. Phanstiel | Buy | 6,100 | $4.74 | +$29K | 31 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay